Is The Cigna Group (CI) One of the Best Dividend Growth Stocks to Buy and Hold for 3 Years?

On May 22, UBS raised its terms proposal connected The Cigna Group (NYSE:CI) to $400 from $375. It reiterated a Buy standing connected the shares. The expert said managed attraction organizations broadly accrued guidance aft stronger-than-expected Q1 results. Favorable respiratory trends and seasonal outgo patterns helped enactment show during the quarter. The expert besides noted that improved Medicare Advantage rates, steadier ACA speech enrollment, and humble Medicaid outperformance strengthened assurance successful borderline recovery. At the aforesaid time, the assemblage continues to woody with outgo pressures tied to specialty drugs, GLP-1 treatments, and behavioral wellness expenses, according to the probe note.

On May 20, Morgan Stanley raised its terms extremity connected CI to $361 from $355. It kept an Overweight standing connected the stock. The steadfast made the alteration aft meetings with absorption that, successful its view, “reinforced the underappreciated” specialty opportunity. The expert added that the company’s September capitalist time is expected to item its increasing semipermanent absorption connected Specialty businesses.

The Cigna Group (NYSE:CI) operates arsenic a planetary wellness institution with 2 concern segments: Evernorth Health Services and Cigna Healthcare.

While we admit the imaginable of CI arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 High Quality Stocks to Buy According to Hedge Funds and 10 Best Long Term Low Risk Stocks to Buy According to Hedge Funds

Disclosure: None. Follow Insider Monkey connected Google News.